Global AI-based Clinical Trial Solution Providers Market 2020-2030 - ResearchAndMarkets.com
Summary
This report features an extensive study of the companies offering AI-based platforms for clinical trial applications, in addition to the current market landscape and their future potential. According to a study conducted by the MIT Sloan School of Management, the rate of clinical success, defined as the proportion of trials that result in approval of the drug/therapy under investigation, was currently estimated to be 14%. The study further demonstrated that there is significant variance in the aforementioned rate across different types of therapies; for instance, for vaccines against infectious diseases, clinical success was estimated to be slightly above 30%, while for investigational anti-cancer drugs, it was 3%. In fact, real-world data analysis is deemed to possess the potential to offer valuable insights from patient/healthcare provider testimonies, in order to drive future trial optimization efforts and facilitate better decision making during clinical research conduct. Amongst other elements, the report features: In order to account for future uncertainties and to add robustness to our model, we have provided three forecast scenarios, portraying the conservative, base, and optimistic tracks of the markets evolution.